Navigation Links
Studies of marine animals aim to help prevent rejection of transplanted organs
Date:4/14/2011

(Santa Barbara, Calif.) Studies of the small sea squirt may ultimately help solve the problem of rejection of organ and bone marrow transplants in humans, according to scientists at UC Santa Barbara.

An average of 20 registered patients die every day waiting for transplants, due to the shortage of matching donor organs. More than 110,000 people are currently waiting for organ transplants in the U.S. alone. Currently, only one in 20,000 donors are a match for a patient waiting for a transplant.

These grim statistics drive scientists like Anthony W. De Tomaso, assistant professor of biology at UCSB, to delve into the cellular biology of immune responses. His studies of the sea squirt shed light on the complicated issue of organ rejection. The latest results are published online today in the journal Immunity.

De Tomaso hopes to understand how it might be possible to "tune" the body's immune response in order to dial down the rejection of a donated organ. Studying cellular responses in simple organisms may also eventually help with autoimmune diseases those in which the body mistakenly attacks itself.

"Right now, when you get a transplant, you're usually on immunosuppressives your whole life," said De Tomaso. "And that's like sort of kicking your immune system in the teeth. What if we could raise the threshold of when you would respond, instead of just shutting the whole system off?"

De Tomaso and his research team study Botryllus schlosseri, a type of sea squirt. This small organism known as a tunicate because of its covering, or "tunic" is a modern day descendant of the vertebrate ancestor, the group to which we belong. Tunicates begin life as swimming tadpoles with primitive backbones, nerves, and musculature that are similar to all vertebrates, but soon transform into stationary creatures. Tunicates latch onto intertidal surfaces and look like flat flowers with each "petal" being a separate, but genetically identical, body.

De Tomaso focuses on what happens when one sea squirt lands next to another. In this case, cells in the sea squirt's fingerlike edges, or "ampullae," recognize the neighboring sea squirt as "self" or "non-self." When the other sea squirt is related, then the two colonies fuse; otherwise, they reject each other. De Tomaso was involved in identifying the gene controlling the choice between fusion and rejection in the sea squirt when he was a postdoctoral fellow at Stanford University

In his current research, De Tomaso studies how the signals on the surface of the sea squirt's cells get translated inside the circuitry of the cell, where the final decision about acceptance or rejection is made. "In the case of Botryllus, what we found is that we have the same kind of integration that goes on in humans, but instead of having a multiple, very complex set of inputs coming in, we only have two," said DeTomaso. "We have also found that we can manipulate each one independently, so we know that somehow they are put together and the two inputs are integrated, and a decision is made about how to respond."

De Tomaso explained that he decided to work on Botryllus because it has a unique way to answer a very complicated question. He hopes to understand the process of rejection or acceptance. "If we could manipulate that process," said Tomaso, "then we could basically teach the immune system to simply ignore certain things. We could say, 'Just don't respond to this. We're going to transfer this bone marrow, just don't kill this bone marrow.' Bone marrow could get in and start making new blood, and it would be fine. To me, that's the most exciting thing long-term for the work."


'/>"/>

Contact: Gail Gallessich
gail.g@ia.ucsb.edu
805-893-7220
University of California - Santa Barbara
Source:Eurekalert  

Related biology news :

1. 3 new studies link eating red to a healthy heart
2. Springer launches Journal of Environmental Studies and Sciences
3. UGA studies explain spread of invasive ladybugs
4. New studies provide beneficial insights expanding the pool of liver grafts and transplants
5. Cytel and Medelis Present an Educational Webinar April 7: Transforming Oncology Development with Adaptive Studies
6. New advances in genetic studies of Fanconi anemia patients
7. Serotonin plays role in many autism cases, studies confirm
8. NIST technique controls sizes of nanoparticle clusters for EHS studies
9. Gulf grows between research practice and participant preferences in genetic studies
10. Single cell studies identify coactivator role in fat cell maturation
11. UTHealth studies cord blood stem cells for pediatric traumatic brain injury
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Studies of marine animals aim to help prevent rejection of transplanted organs
(Date:8/15/2017)... , Aug. 15 2017   ivWatch LLC , a ... intravenous (IV) therapy, today announced receipt of its ISO 13485 Certification, ... by the International Organization for Standardization (ISO®). ... ivWatch Model 400 Continuous Monitoring device for the early ... "This is an ...
(Date:5/23/2017)... robotic gym for the rehabilitation and functional motor sense evaluation of lower ... . The first 30 robots will be available from June in ... The technology was developed and patented at the IIT laboratories and has ... to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:4/19/2017)... 19, 2017 The global military ... is marked by the presence of several large global ... by five major players - 3M Cogent, NEC Corporation, ... for nearly 61% of the global military biometric market ... the global military biometrics market boast global presence, which ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... CA (PRWEB) , ... October 11, 2017 , ... ... upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding the ... system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights ... (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life ... for the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan ... The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary ...
Breaking Biology Technology: